CIRCULATION:非阵发性房颤患者导管消融的临床预后仍不理想

2012-12-20 CIRCULATION 互联网 czs890510

导管消融是治疗房颤的一种有效地治疗手段,尤其是对于药物治疗效果不佳或不能耐受药物治疗的患者,近年来,导管消融的适应症已扩展到非阵发性房颤患者,但是目前还缺乏非阵发性房颤导管消融的长期成功率的数据,该项研究旨在调查非持续房颤患者导管消融治疗的长期预后。 研究方法:共入选88例非阵发性房颤患者,所有患者均进行了阶梯式的导管消融术(肺静脉隔离+左房基质改良),术后所有患者均接受8周的抗心律失常药物治疗

导管消融是治疗房颤的一种有效地治疗手段,尤其是对于药物治疗效果不佳或不能耐受药物治疗的患者,近年来,导管消融的适应症已扩展到非阵发性房颤患者,但是目前还缺乏非阵发性房颤导管消融的长期成功率的数据,该项研究旨在调查非持续房颤患者导管消融治疗的长期预后。

研究方法:共入选88例非阵发性房颤患者,所有患者均进行了阶梯式的导管消融术(肺静脉隔离+左房基质改良),术后所有患者均接受8周的抗心律失常药物治疗以防止早期复发,并在术后每1-3月进行门诊随访,平均随访时间为36.8月,随访内容包括Holter和/或事件记录器检查,复发定义为手术2月后出现的持续时间大于30秒的房性心律失常发作,并通过心电图记录证实。无复发定义为在未使用任何抗心律失常药物的情况下房颤未再发作。

结果:随访期间有63例患者出现复发,占71.6%;多因素分析提示CHADS2评分≥3分和左房内径是复发的预测因子。对于CHADS2评分≥3分及左房内径>44mm的患者,所有的复发均发生在初次手术后1年内。通过2次手术后无复发率升至47.7%,3次手术的无复发率为51.1%。

结论:非阵发性房颤长时间一次导管消融手术后长时间无复发率仅为28.4%;多次手术可提高无复发率;CHADS2评分和左房内径可帮助临床医师识别易复发的患者。

房颤相关的拓展阅读:

doi: 10.1161/​CIRCEP.111.968032
PMC:
PMID:

Clinical Outcome of Catheter Ablation in Patients with Non-Paroxysmal Atrial Fibrillation: The Results of 3-Year Follow Up

Tze-Fan Chao1, Hsuan-Ming Tsao2, Yenn-Jiang Lin1, Chin-Feng Tsai3, Wei-Shiang Lin4, Shih-Lin Chang1, Li-Wei Lo1, Yu-Feng Hu1, Ta-Chuan Tuan1, Kazuyoshi Suenari5, Cheng-Hung Li1, Beny Hartono6, Hung-Yu Chang7, Kibos Ambrose6, Tsu-Juey Wu8 and Shih-Ann Chen1*

Background—Catheter ablation of atrial fibrillation (AF) became an effective therapy for patients with drug-refractory AF and the indications have broadened to include non-paroxysmal AF patients. However, data about the long-term effectiveness of ablation in patients with non-paroxysmal AF are lacking. The aim of the present study was to investigate the long-term ouctomces of catheter ablation in patients with non-paroxysmal AF. Methods and Results—A total of 88 non-paroxysmal AF patients who received a stepwise catheter ablation (isolation of the pulmonary veins plus substrate modification) from 2006-2008 were enrolled. Freedom of recurrence was defined as the absence of atrial arrhythmias without using any antiarrhythmic agents after the catheter ablation. There were 63 patients (71.6%) suffering from recurrences (47 patients with AF and 16 patients with atrial flutter/atrial tachycardia) after the initial procedure during a median follow-up period of 36.8 months. A CHADS2 score of ≥3 and the left atrial (LA) diameter were significant predictors of recurrences in the multivariable analysis. Of the patients with CHADS2 scores of ≥3 and an LA dimension ≥44mm, all experienced recurrences within 1 year after the initial procedure. The overall recurrence-free rate could increase to 47.7% after the second procedure and 51.1% after the third procedure. Conclusions—The long-term recurrence-free rate of ablation in non-paroxysmal AF was only 28.4% after a single procedure, and multiple procedures were necessary to raise the recurrence-free rate. The CHADS2 score and LA dimension may help us to idenfy patients who will experience recurrences after catheter ablations of non-paroxysmal AF.

版权声明:
本网站所有注明“来源:梅斯医学”或“来源:MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明“来源:梅斯医学”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (0)
#插入话题